ELISA Kit for Lipopolysaccharide Binding Protein (LBP)
SEB406HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Lipopolysaccharide Binding Protein (LBP)
- Delivery Days Customer12
- Assay Detection Range3.12-200ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lipopolysaccharide Binding Protein (LBP) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 1.17ng/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Lipopolysaccharide Binding Protein (LBP). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Karow F, Smiljanovic B, Grün JR, et al. Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint. Arthritis Res Ther. 2021,23(1):246. doi: 10.1186/s13075-021-02623-7Read this paper
- Orsso CE, Peng Y, Deehan EC, et al. Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance. Microorganisms. 2021,9(7). doi: 10.3390/microorganisms9071490Read this paper
- Kim H, Kim YJ, Jeong HY, et al. A standardized extract of the fruit of Hovenia dulcis alleviated alcohol-induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. J Ethnopharmacol. 2017,209:167-174. doi: 10.1016/j.jep.2017.07.028Read this paper
- Agiasotelli D, Alexopoulou A, Vasilieva L, et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int. 2017,37(4):576-582. doi: 10.1111/liv.13264Read this paper
- Kaltsa G, Bamias G, Siakavellas SI, et al. Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis. Ann Gastroenterol. 2016,29(1):63-70.Read this paper
- Upur H, Chen Y, Kamilijiang M, et al. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study. BMC Complement Altern Med. 2015,15:9. doi: 10.1186/s12906-015-0526-6Read this paper
- Jialal I, Rajamani U, Adams-Huet B, et al. Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. Atherosclerosis. 2014,236(1):182-7. doi: 10.1016/j.atherosclerosis.2014.06.022Read this paper
- Xiao S, Fei N, Pang X, et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 2014,87(2):357-67. doi: 10.1111/1574-6941.12228Read this paper
- Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, et al. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci. 2013,58(10):3029-36. doi: 10.1007/s10620-013-2693-yRead this paper
- Papadopoulos N, Bakhtiary F, Grün V, et al. The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients. Perfusion. 2013,28(4):306-14. doi: 10.1177/0267659113478450Read this paper



